India Globalization Capital Inc (IGC)

India Globalization Capital Inc (IGC) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $25.4M; returns 1 day -0.7%, 1 week +0.0%, 1 year -35.3%.

India Globalization Capital, Inc. (IGC), operating primarily as IGC Pharma, is a clinical-stage pharmaceutical company focused on developing treatments for Alzheimer's disease. The company has shifted its focus from infrastructure projects to life sciences, with its value heavily tied to its drug pipeline.

Groups IGC belongs to

• Alzheimer's Disease
• Clinical Stage Biotech
• Biotechnology
• Pharmaceuticals
• Life Sciences
• Cannabis
• CNS Disorders
• Clinical Stage
• Healthcare

IGC financial model: income statement, cash flow and balance sheet